Evidence map›Paper›PMID 31964113›Full record

ArticleJournal of pathology and translational medicine2020

Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution.

Myunghee Kang, Seung Yeon Ha, Hyun Yee Cho, Dong Hae Chung, Na Rae Kim, Jungsuk An, Sangho Lee, Jae Yeon Seok, Juhyeon Jeong

Open access · goldAbstract read
In one paragraph

Article in Journal of pathology and translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea.International journal of environmental research and public health · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Myunghee KangDepartment of Pathology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Seung Yeon HaDepartment of Pathology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Hyun Yee ChoDepartment of Pathology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Dong Hae ChungDepartment of Pathology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Na Rae KimDepartment of Pathology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Jungsuk AnDepartment of Pathology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Sangho LeeDepartment of Pathology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Jae Yeon SeokDepartment of Pathology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Juhyeon JeongDepartment of Pathology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Gachon University · KR

Funding

The Korean Society for Cytopathology
6 · The paper itself

Abstract

backgroundThe decrease in incidence of cervical dysplasia and carcinoma has not been as dramatic as expected with the development of improved research tools and test methods. The human papillomavirus (HPV) test alone has been suggested for screening in some countries. The National Cancer Screening Project in Korea has applied Papanicolaou smears (Pap smears) as the screening method for cervical dysplasia and carcinoma. We evaluated the value of Pap smear and HPV testing as diagnostic screening tools in a single institution.

methodsPatients co-tested with HPV test and Pap smear simultaneously or within one month of each other were included in this study. Patients with only punch biopsy results were excluded because of sampling errors. A total of 999 cases were included, and the collected reports encompassed results of smear cytology, HPV subtypes, and histologic examinations.

resultsSensitivity and specificity of detecting high-grade squamous intraepithelial lesion (HSIL) and squamous cell carcinoma (SCC) were higher for Pap smears than for HPV tests (sensitivity, 97.14%; specificity, 85.58% for Pap smears; sensitivity, 88.32%; specificity, 54.92% for HPV tests). HPV tests and Pap smears did not differ greatly in detection of low-grade squamous intraepithelial lesion (85.35% for HPV test, 80.31% for Pap smears). When atypical glandular cells were noted on Pap smears, the likelihood for histologic diagnosis of adenocarcinoma following Pap smear was higher than that of high-risk HPV test results (18.8 and 1.53, respectively).

conclusionsPap smears were more useful than HPV tests in the diagnosis of HSIL, SCC, and glandular lesions.

Indexed as

Early detection of cancerHuman papillomavirus DNA testsPapanicolaou testSensitivityUterine cervical neoplasms

Identifiers

PMID31964113
PMCPMC6986973
OpenAlexW3000243688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.